Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in NVCT — Nuvectis Pharma, Inc.

CIK 73124 CHICAGO, IL
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,698,068
+$1,737,911 QoQ
Shares Held
146,714
+18.1% QoQ
Ownership
0.450%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 82 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 98% Shared 2% None 0%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. NVCT ranks #209 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in NVCT

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,698,068 146,714
2026-03-31 $960,157 124,212
2025-12-31 $878,857 116,405
2025-09-30 $641,977 106,641
2025-06-30 $820,332 109,817
2025-03-31 $371,825 38,058
2024-12-31 $139,170 25,725
2024-09-30 $95,940 15,253
2024-06-30 $315,404 49,827
2024-03-31 $509,194 62,097
2023-12-31 $513,525 61,574
2023-09-30 $704,914 54,687
2023-06-30 $856,534 53,634